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ABSTRACT 
Objective 
The association of the circulating serum vitamin D metabolite 25-hydroxyvitamin D (25OHD) 
with atherosclerotic burden is unclear, with previous studies reporting disparate results. 
Method 
Psychological, social and biological determinants of ill health (pSoBid) is a study of participants 
aged 35-64 years from Glasgow who live at extremes of the socioeconomic spectrum. Vitamin D 
deficiency was defined as 25OHD <25nmol/L, as per convention. Cross-sectional associations 
between circulating 25OHD concentrations and a range of socioeconomic, lifestyle, and 
biochemistry factors, as well as carotid intima media thickness (cIMT) and plaque presence were 
assessed in 625 participants.  
Results 
Geometric mean levels of circulating 25OHD were higher among the least deprived (45.6 
nmol/L, 1-SD range 24.4-85.5) versus most deprived (34.2 nmol/L, 1-SD range 16.9-69.2; 
p<0.0001). In the least deprived group 15% were “deficient” in circulating 25OHD versus 30.8% 
in the most deprived (χ2 p<0.0001). Log 25OHD was 27% lower among smokers (p<0.0001), 
20% higher among the physically active versus inactive (p=0.01), 2% lower per 1kg/m2 increase 
in body mass index (BMI) (p<0.0001), and showed expected seasonal variation (χ2 p<0.0001). 
Log 25OHD was 13% lower in the most versus least deprived independent of the aforementioned 
lifestyle confounding factors (p=0.03). Circulating 25OHD concentrations were not associated 
with atherosclerotic burden in univariable models; cIMT (effect estimate 0.0mm [95% CI -0.02, 
0.02]); plaque presence (OR 1.15 [0.85, 1.57]), or in multivariable models. 
Conclusion 
There is no strong association of 25OHD with cIMT or plaque presence, despite strong evidence 
25OHD associates with lifestyle factors and socioeconomic deprivation. 
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INTRODUCTION 
It has been widely reported that vitamin D deficiency, as assessed by measuring the major 
circulating vitamin D precursor 25-hydroxyvitamin D (25OHD), may adversely affect the 
cardiovascular system [1]. Prospectively, several studies report a link between low circulating 
25OHD concentrations and higher risk for incident CVD events [2-4], as well as a range of other 
acute and chronic diseases. Such research has led to recommendations regarding desirable 
25OHD levels, and the requirement for vitamin D supplements in large proportions of the 
population [5]. As such, routine clinical biochemistry departments locally and elsewhere, are 
reporting vastly increased clinical demand for 25OHD measurements [6]. 
 
We have previously argued, as have others, that observational data may be confounded and 
subject to reverse causality, these limitations being of particular relevance for 25OHD [6-8]. 
There is no convincing evidence from randomized trials that vitamin D supplements can reduce 
CVD risk, despite reported observational associations with risk [9]. To advance the literature, we 
aimed to investigate the association of circulating 25OHD with measures of atherosclerotic 
burden, whilst also investigating (and therefore adjusting for) any association of 25OHD with 
socioeconomic status and related characteristics. Carotid intima media thickness (cIMT) and 
plaque presence are emerging as potentially strong markers of CVD risk in general populations, 
with plaque presence is perhaps a stronger predictor of cardiovascular events than cIMT [10]..   
 
The pSoBid (psychological, social and biological determinants of ill health) study comprises a 
cross section of men and women from either socially deprived or socially advantaged areas in 
Greater Glasgow, who had cIMT and plaque presence measured. We hypothesised that 25OHD 
would be lower in more deprived individuals independently of measured lifestyle factors, and 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
5 
that such associations could at least partially explain a hypothesised association of 25OHD with 
markers of carotid atherosclerosis. 
 
METHODS 
Participants 
The recruitment procedure for the pSoBid study has been described in detail previously [11]. 
Briefly, participants were invited to participate in the study at random (via ten general practice 
lists) from areas known to be at the extremes of the socioeconomic continuum in Glasgow, 
Scotland, such that approximately equal numbers of males and females across three age 
categories (35-44, 45-54, and 55-64 years) would be recruited. Socioeconomic selection was 
based on Scottish Index for Multiple Deprivation (SIMD) 2004 scores which is a small area-
based score of deprivation based on data from public records relating to 38 indicators across 7 
domains: income; employment; health; education, skills and training; housing; geographic 
access; crime [12] (see supplementary data). As an illustration annual household income was 
<£15,000 among in 60% of the most deprived participants, and >£45,000 among 60% of the 
least deprived participants. SIMD is currently used for clinical cardiovascular risk assessment in 
Scotland (the ASSIGN risk score [13]). Those recruited were either most deprived (bottom 5% 
of SIMD score) or least deprived (top 20% of SIMD). A total of 666 participants recruited 
between Dec 2005 and May 2007 (616 underwent ultrasound measurements of the carotid artery) 
[11]. This group comprised 171 males and 171 females in the least deprived group, and 156 
males and 168 females in the most deprived group. Only 19 participants (2.9%) were born 
outside of the United Kingdom or Republic of Ireland. Comparison of participants with non-
participants has been reported previously [14]. Participants underwent a routine physical 
examination (including measurement of blood pressure, body mass index [BMI], and waist hip 
ratio [WHR]) and lifestyle questionnaire [11]. Dysglycaemia was identified through current 
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treatment for diabetes, and a fasting measure of plasma glucose [11].   Physical activity was 
assessed using a validated questionnaire and categorised those who were inactive, moderately 
inactive, moderately active, and active. The study was reviewed and approved by the Glasgow 
Royal Infirmary Research Ethics Committee; all participants gave written informed consent. 
 
Carotid intima-media thickness and plaque count 
Doppler velocity in right and left internal carotid arteries was recorded in order to identify 
carotid artery stenosis using an ACUSON Sequoia 512 Ultrasound System with an L7 5-12 MHz 
linear array broadband transducer (Siemens Medical Solutions, Erlangen, Germany). Images of 
the distal 1 cm of the common carotid artery, the carotid bulb and the proximal internal carotid 
artery were recorded on the left and right side, and intima-media thickness of the far wall of the 
artery determined (using eTrack software). At the six sites, the number of carotid plaques was 
determined [15], and counted. Plaque was defined as a focal structure encroaching into the 
arterial lumen of at least 0.5mm or 50% of the surrounding IMT value, or demonstrating a 
thickness >1.5mm as measured from media-adventitia interface to intima-lumen interface. In 
order to adjust for unreadable images, total plaque count for each subject was divided by the 
number of readable images present and multiplied by 6 (the maximum possible number of 
images per subject) [15]. Nurses performing scans were subject to reproducibility checks as 
detailed [14]. Reading of the scans was performed off-line by a reader who was blinded to the 
identity of the participants. 
 
Analytical procedures 
Fasting venous blood samples were taken on the same visit as the ultrasound examination. We 
have a high-throughput method for the measurement of 25OHD3 and D2 using an automated 
solid-phase extraction (SPE) procedure with liquid chromatography-tandem mass spectrometry 
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[16].  The lower limit of sensitivity was reported as 7.5nmol/L for 25OHD2 and for 25OHD3. 
Within- and between-assay precision was below 10%. Our method is currently in routine clinical 
use. Results are reported as total 25OHD (25OHD2 + 25OHD3). Measurements of 25OHD were 
made by technicians who did not have access to the prior cIMT or plaque measurements, and 
were therefore blinded. A total 25OHD of <25nmol/L (10ng/ml) was defined as “deficiency”, by 
convention frequently cited in the literature. 
 
Statistical Analysis 
Descriptive statistics are presented as mean (SD) and median (interquartile range, IQR) for 
continuous variables and count (%) for categorical outcomes. Due to skew, 25OHD is presented 
as a geometric mean and geometric standard deviation (i.e. the square root of the factor the 
geometric mean must be divided or multiplied by to give the 95% range). Associations between 
25OHD and demographic and socioeconomic factors are presented adjusting for age, sex, and 
month of participation, and again with further adjustment for BMI, physical activity level and 
smoking status. Linear regression models were used, with log 25OHD as the response variable. 
Effect estimates are reported as percentage differences associated with a 10-year increase in age, 
or for categorical variables, relative to a reference category. Associations between 25OHD and 
cardiovascular risk factors were assessed using linear regression models with the risk factor (or 
its logarithm – see Table 2 for details) as the outcome, and the logarithm of 25OHD as a 
predictor (scaled by the standard deviation (SD) of log 25OHD), with adjustment for age, sex 
and deprivation group. Effect estimates are reported as the regression coefficient, interpretable as 
the absolute change in the response (or in the logarithm of the response) associated with a 1-SD 
increase in log 25OHD. All reported p-values are two sided. No adjustments were made for 
multiple statistical comparisons, so our p-values must be considered as descriptive measures of 
the strength of evidence for the observed associations. Significance levels of <5% have been 
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treated as suggestive of true associations, with smaller p-values representing greater levels of 
evidence. 
 
As an indication of the power of the study, we had 80% power to detect a difference in 25OHD 
between those with and without plaques of 17% (or 24% in the least deprived group alone).  
 
Analyses were conducted in S-Plus (TIBCO software) for Windows v8.1. 
 
RESULTS 
Baseline characteristics 
The baseline characteristics of the 666 study participants by deprivation status have been 
previously reported [14]. Most classical CVD risk factors, including CRP, were more adverse in 
the most socioeconomically deprived group (p<0.0001 for all) with the exception of blood 
pressure and total and HDL cholesterol, the latter two variables being slightly elevated in the 
least deprived group. As a result, LDL:HDL ratio did not differ between the two deprivation 
groups (mean of 2.37mmol/L in both; p=0.91). Mean cIMT was 0.68mm (standard deviation 
±0.12) in the least deprived group, and 0.70mm (±0.16) in the most deprived (p=0.015). There 
was at least one plaque present in 43.1% of the least deprived, and 58.3% of the most deprived 
group, with a mean plaque score of 1.0 in the least deprived group and 1.7 in the most deprived 
group (p<0.0001). 
 
A total of 625 participants (93.8% of included participants) had given plasma samples for which 
aliquots were sufficient for the LC-MS/MS 25OHD assay. None of the cohort had analytically 
detectable 25OHD2 and 96.5% had detectable 25OHD3. The standard deviation of log total 
25OHD was 0.68 in the whole population. Geometric mean concentration of 25OHD were 
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higher among the least deprived (45.6 nmol/L, 1-SD range 24.4-85.5) versus most deprived (34.2 
nmol/L, 1-SD range 16.9-69.2; p<0.0001). A total of 141 patients (22.6%) could be defined as 
being deficient in circulating 25OHD (<25nmol/L), 49 (15%) in the least deprived group and 92 
(30.8%) in the most deprived group (χ2 p<0.0001).  
 
Associations of circulating 25OHD concentrations with seasonal variation 
Circulating log 25OHD concentrations were strongly associated with month of participation 
(blood sampling) across all participants (χ2 p<0.0001) and in both deprivation groups (Figure 1). 
Median 25OHD concentrations were lowest in February (33.1nmol/L; IQR 22.0-49.9nmol/L, 
n=103) and highest in June (70.8nmol/L; IQR 44.7-103.5nmol/L, n=40). There was no evidence 
of a difference in month of participation by deprivation group (χ2 p=0.69). 
 
Associations of circulating 25OHD with selected demographic and socioeconomic variables 
Log 25OHD concentrations showed no strong associations with either age or sex (Table 1). After 
adjusting for age, sex, month, physical activity and BMI, current smokers had 27% lower log 
25OHD levels than never smokers (p<0.0001). In age, sex, month, BMI and smoking adjustment 
models, log 25OHD levels showed positive associations with greater physical activity; difference 
between the extreme active and inactive groups was 20%, p=0.01. 
 
For markers of deprivation, log 25OHD concentrations were 23% lower in the most deprived 
group in adulthood (SIMD) after adjusting for age, sex and month (p<0.0001). This association 
of 25OHD with deprivation remained evident after additionally adjusting for BMI, smoking and 
physical activity (difference 13%; p=0.03). In addition, log 25OHD concentrations were 
positively and independently associated with annual income (being 16-33% higher in those 
earning >£25K, compared to those earning <£15K). In contrast, there was no strong evidence of 
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an association of log 25OHD with either educational attainment or childhood markers of 
deprivation (including number of siblings, people per room, or leg length) in either model (Table 
1).  
 
After adjustment age, sex, deprivation, month of participation, income, smoking status, BMI, and 
physical activity 25OHD should no strong associations with continuous classical cardiometabolic 
or inflammatory risk factors (supplementary data). 
 
Associations of 25OHD with markers of atherosclerotic burden 
Of the 625 participants with 25OHD data, there were 311 individuals with, and 302 without 
plaques (12 missing). We related 1 unit increase in log vitamin D to odds ratio (OR) of any 
plaque presence, and to effect size on the cIMT (Table 2). There was no strong evidence of an 
association of increasing 25OHD concentrations with risk of plaque presence or cIMT in the 
whole group in univariable or adjusted models. There was weak evidence that 25OHD may be 
associated with plaque presence in men only in unvariable models, although there was no 
evidence that this association was any different between men and women (p=0.13). 
 
DISCUSSION 
Circulating 25OHD concentrations were “deficient” in a sizeable proportion (22.6%) of this 
selected cohort living in Glasgow, but deficiency was more prevalent in socially deprived 
communities. This association of deprivation with 25OHD was only partially explained by 
markers of poor health among the deprived. There was no evidence of an association of 25OHD 
with markers of carotid atherosclerosis (cIMT or plaque presence).  
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A previous study in 390 consecutive diabetic patients attending a clinic showed that 
hypovitaminosis D (defined as 25OHD <15nmol/L) is associated with greater cIMT [17]. People 
with severe or long-standing type 2 diabetes (resulting in diabetic nephropathy) have lower 
25OHD than people with diabetes but without complications [18]. We hypothesise that people 
with more severe diabetes are likely to have reduced physical activity and sunlight exposure, 
resulting in a confounded associations between 25OHD and diabetes severity/duration and 
atherosclerosis indices. Indeed, other population based studies have also reported that circulating 
25OHD concentrations are not strongly related to cIMT [19-21]. One recent study of 203 older 
people in North America reports no association of 25OHD with cIMT or plaque count in the 
whole cohort, but a borderline significant association in those with plaques (for cIMT and 
maximal plaque thickness measures), although that study did not adjust for measures of 
deprivation. [22]. 
 
Socioeconomic deprivation is associated with risk of a large number of chronic diseases, and 
mortality, and is associated with CVD risk independent of classical risk factors [23]. Our detailed 
observations that social deprivation (and related factors such as income) is associated with 
25OHD concentrations extends findings from the National Diet and Nutrition Survey cohort, 
suggesting 25OHD concentrations are lower among UK state benefit recipients than non-
recipients [24], and data from the 1958 cohort [25]. Our hypothesis generating observation that 
25OHD is lower among deprived groups particularly in winter (but perhaps not summer) 
requires further study. Clearly, increased background exposure to sunlight during summer may 
ameliorate differences in 25OHD between deprivation groups which may be more evident in 
winter months. 
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Association of 25OHD with social deprivation may be one explanation for the discrepancy 
between epidemiological study of associations between 25OHD and CVD risk, and thus far, lack 
of efficacy of vitamin D supplementation in RCTs to prevent chronic or acute disease not related 
to bone mineral metabolism [8, 26-29]. Further, our results suggest that education may be 
relatively weakly associated with serum 25OHD, and that other markers of deprivation may be 
better linked to 25OHD levels.  It may be more robust and appropriate to adjust for multiple 
markers of deprivation simultaneously rather than just one, a procedure shown by others to be 
relevant to investigating the links of vitamin C to CVD risk [30].   
 
We recognise strengths and limitations in the present study. We measured 25OHD by a routine 
NHS tandem mass spectrometry method which is calibrated against international standards. 
Plasma levels of 25OHD2 were frequently undetectable, but in our experience this is reflective of 
what is generally seen in clinical practice, and generally 25OHD2 levels mean little in terms of 
clinical interpretation. Discussion of the generalisability of results in cross-sectional studies is 
often challenging. Glasgow is broadly similar to many other UK post-industrial cities although in 
this study only individuals from the two extremes of social deprivation were included. Given that 
we observe a significant gradient in both 25OHD and atherosclerotic burden between deprivation 
groups, we would expect to see an association between 25OHD and atherosclerosis if one 
existed. However, we cannot exclude the possibility that, by design, we do not detect more subtle 
associations which might be evident in a general population. We do not have detailed dietary or 
sunlight exposure data to allow dietary intake of vitamin D to be examined as a determinant of 
vitamin D status in pSoBid. We have not adjusted for ethnicity; of all participants, only 19 
(2.9%) participants were born outside the United Kingdom or Ireland. Finally we cannot rule out 
the possibility that pSoBid was underpowered to detect an association between 25OHD levels 
and cIMT or carotid plaques in a multivariable model, although our power calculations suggest 
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any association of 25OHD with atherosclerosis we might have been underpowered to detect 
would be of questionable clinical significance.  
 
In conclusion, 25OHD concentrations are not strongly associated with either cIMT or plaque 
presence in the pSoBid study. 25OHD is however associated inversely with several measures of 
social deprivation independently of the primary determinants of poor health among the deprived 
(obesity, smoking, and physical inactivity). Therefore future studies relating circulating 25OHD 
concentrations to risk of chronic illness or death should, wherever possible, adjust for 
deprivation or income or for multiple markers of deprivation rather than education alone.  
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Table 1: Associations between 25OHD concentrations (outcome) and selected exposure variables after 
adjustment for age, sex, month of participation, and (optionally) BMI, smoking status, and physical 
activity.  
Relative Effect Estimate (95% CI), p-value 
Predictor 
Variable 
 
Adj. for age, sex, month 
Also adj. for 
BMI, activity and smoking,  
as appropriate 
Adjustment variables 
Age (+10 years) 1.04 (0.97, 1.11), p=0.25 1.07 (1.00, 1.14), p=0.05 
Sex 
(vs. Female) 
Male 0.98 (0.89, 1.09), p=0.72 0.98 (0.88, 1.08), p=0.69 
BMI (+1 kg/m2) - 0.98 (0.97, 0.99), p<0.0001 
Activity Level 
(vs. Inactive) 
Moderately Inactive 
Moderately Active 
Active 
- 
1.13 (0.98, 1.31), p=0.10 
1.12 (0.98, 1.29), p=0.10 
1.20 (1.04, 1.38), p=0.01 
Smoking 
(vs. Never Smokers) 
Former Smokers 
Current Smokers 
- 
0.99 (0.88, 1.11), p=0.85 
0.73 (0.64, 0.83), p<0.0001 
Adult Markers of Social Deprivation 
Deprivation 
(vs. Least Deprived) 
Most Deprived 0.77 (0.69, 0.85), p<0.0001 0.87 (0.78, 0.98), p=0.03 
Annual Income 
(vs. < 15,000) 
16-25,000 
26-35,000 
36-45,000 
> 45,000 
1.13 (0.97, 1.32), p=0.13 
1.25 (1.03, 1.50), p=0.02 
1.53 (1.26, 1.86), p<0.0001 
1.35 (1.18, 1.54), p<0.0001 
1.12 (0.95, 1.32), p=0.17 
1.16 (0.95, 1.42), p=0.15 
1.33 (1.08, 1.65), p=0.01 
1.17 (1.00, 1.37), p=0.05 
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Effects are the relative change in 25OHD for a specified change in continuous variables, or relative to a 
referent group for categorical variables.  
 
 
 
Education 
(vs. ≤ 11 yrs) 
12-13 yrs 
14-16 yrs 
≥ 17 yrs 
1.09 (0.94, 1.27), p=0.23 
1.06 (0.93, 1.21), p=0.38 
1.14 (0.99, 1.31), p=0.06 
1.00 (0.86, 1.17), p=0.99 
0.91 (0.79, 1.05), p=0.19 
0.93 (0.80, 1.08), p=0.35 
Childhood Markers of Social Deprivation 
Number of Siblings 
(vs. None) 
1-2 
3 
≥ 4 
1.16 (0.99, 1.35), p=0.06 
1.27 (1.06, 1.52), p=0.01 
1.10 (0.92, 1.33), p=0.29 
1.12 (0.96, 1.31), p=0.14 
1.34 (1.12, 1.60), p=0.002 
1.15 (0.95, 1.38), p=0.15 
People per Room 
(vs. ≤ 1) 
> 1, ≤ 1.5 
> 1.5 
1.03 (0.91, 1.17), p=0.62 
1.03 (0.91, 1.16), p=0.68 
1.13 (0.99, 1.27), p=0.06 
1.13 (0.99, 1.28), p=0.06 
Leg Length 
(vs. ≤ 75cm) 
75.1-80cm 
80.1-85cm 
> 85cm 
1.15 (0.98, 1.34), p=0.08 
1.15 (0.97, 1.35), p=0.11 
1.19 (0.98, 1.43), p=0.07 
1.12 (0.96, 1.30), p=0.15 
1.05 (0.88, 1.24), p=0.61 
1.02 (0.84, 1.24), p=0.82 
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Table 2 Association of 1 unit increase in log 25OHD with plaque presence (odds ratio) and cIMT (effect 
size) 
 
Multivariable adjustment model includes age, sex, readable scans (plaque presence only), HDL and LDL 
cholesterol, triglycerides, systolic and diastolic blood pressure, hypertension, smoking, fasting glucose, 
dysglycaemia treatment, physical activity, deprivation, and month of participation. 
Interaction tests compare associations in males vs. females and most deprived vs. least deprived 
respectively 
 
 
 Plaque presence Odds Ratio 95% CI P-value P-interaction 
Univariable All participants 0.88 (0.75 : 1.03) 0.10  
 Males only  0.75 (0.58 : 0.97) 0.027 
 Females only 0.97 (0.78 : 1.19) 0.75 
0.13 
 Most deprived 0.80 (0.64 : 1.01) 0.065 
 Least deprived 1.10 (0.86 : 1.40) 0.44 
0.066 
Multivariable All participants 0.92 (0.73 : 1.17) 0.51  
      
 cIMT 
Effect size 
(mm) 
95% CI   
Univariable All participants 0.000 (-0.011 : 0.012) 0.99  
 Males only  0.008 (-0.010 : 0.025) 0.41 
 Females only -0.006 (-0.021 : 0.009) 0.45 
0.26 
 Most deprived 0.000 (-0.016 : 0.017) 0.96 
 Least deprived 0.004 (-0.013 : 0.021) 0.64 
0.77 
Multivariable All participants -0.007 (-0.018 : 0.005) 0.25  
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FIGURE LEGENDS 
 
Figure 1 
 
Variation in 25OHD concentrations by month of participation in the two deprivation groups. Point 
estimates are geometric means, error bars are 95%CI. 
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• We investigated circulating 25OHD at extremes of deprivation 
• 25OHD is not associated with cIMT or plaques in the carotid artery 
• 25OHD is strongly associated with certain markers of socioeconomic 
deprivation 
• Observational studies of 25OHD should be cautious in causal inference, and 
adjust for SES 
